HBGHX Holdings Information

HBGHX is a mutual fund with a total of 84 individual holdings. The top holdings are Eli Lilly and Company stock at 12.43%, Johnson & Johnson at 6.60%, Merck & Co. at 6.58%, UnitedHealth Group at 4.70%, and AbbVie at 3.42%.

Total Holdings

Top 10 Percentage

47.90%

Asset Class

Equity

Fund Category

Health

Assets

110.99M

Forward PE Ratio

20.61

Breakdown by Asset Class

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	LLY	Eli Lilly and Company	12.43%	11,684
2	JNJ	Johnson & Johnson	6.60%	29,313
3	MRK	Merck & Co., Inc.	6.58%	57,698
4	UNH	UnitedHealth Group Incorporated	4.70%	12,747
5	ABBV	AbbVie Inc.	3.42%	15,306
6	ISRG	Intuitive Surgical, Inc.	2.98%	8,447
7	ELV	Elevance Health, Inc.	2.95%	8,597
8	CVS	CVS Health Corporation	2.92%	31,846
9	VRTX	Vertex Pharmaceuticals Incorporated	2.68%	6,088
10	DHR	Danaher Corporation	2.64%	15,625
11	n/a	Usd	2.48%	2,790,510
12	EW	Edwards Lifesciences Corporation	2.41%	30,064
13	ABT	Abbott Laboratories	2.09%	25,958
14	COR	Cencora, Inc.	2.06%	8,209
15	CAH	Cardinal Health, Inc.	1.81%	8,573
16	HCA	HCA Healthcare, Inc.	1.69%	4,900
17	TMO	Thermo Fisher Scientific Inc.	1.64%	3,678
18	REGN	Regeneron Pharmaceuticals, Inc.	1.56%	2,822
19	BIIB	Biogen Inc.	1.40%	7,312
20	A	Agilent Technologies, Inc.	1.35%	11,491
21	LON: GSK	GSK plc	1.20%	51,586
22	BSX	Boston Scientific Corporation	1.18%	31,220
23	SYK	Stryker Corporation	1.17%	4,189
24	CNC	Centene Corporation	1.16%	20,353
25	MDT	Medtronic plc	1.01%	14,617

Showing 25 of 84 holdings

Subscribe to see the full list

Activate Now

As of Jun 30, 2026